Indena's SabaSelect Chosen By NIH for Sponsored Clinical Trial

Saw palmetto extract selection by an independent panel of experts is a strong endorsement of the high quality of Indena's herbal products

Milan, February 5th 2002 - Indena has been chosen as the supplier of saw palmetto extract - Sabalselect. - for the first large clinical trial of this herbal product to take place in the United States. Investigators at the University

After over a year of careful planning and preparation, the clinical trial is now open for enrolment and will be underway at the San Francisco VA Medical Centre. Over a hundred patients have been screened for eligibility and interest, and the first set of patients randomly assigned to saw palmetto or placebo capsules. During the year, the investigators hope to enrol 224 patients for observation over the ensuing 12 months, whilst the study shouILY: Arial">, Germany, France and Spain, where ethical specialities containing Serenoa repens are registered, phytotherapy now represents the first-line therapeutical option and one of the most widely used active principles to treat BPH. Currently, in the United States phytotherapeutical agents are available asSend FREE Valentine eCards with Yahoo! Greetings!

Contact: Laura Bertossi
E-mail: [email protected]
Phone: 917 742 1701 

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.